Bimatoprost Ophthalmic Solution 0.03%"TS" (ビマトプロスト点眼液0.03%「TS」) Jaapan - inglise - すりの適正使用協議会 RAD-AR Council, Japan

bimatoprost ophthalmic solution 0.03%"ts" (ビマトプロスト点眼液0.03%「ts」)

rohto nitten co., ltd. - bimatoprost - limpid and colorless sterile aqueous eye solution, (cap) deep green, (bottle) white translucent, (accompanying bag) clear [shading]

Bimatoprost Ophthalmic solution 0.03%"NITTEN" (ビマトプロスト点眼液0.03%「日点」) Jaapan - inglise - すりの適正使用協議会 RAD-AR Council, Japan

bimatoprost ophthalmic solution 0.03%"nitten" (ビマトプロスト点眼液0.03%「日点」)

rohto nitten co., ltd. - bimatoprost - limpid and colorless sterile aqueous eye solution, (cap) peacock green, (bottle) white translucent, (accompanying bag) clear [shading]

Bimatoprost ophthalmic solution 0.03% "SEC" (ビマトプロスト点眼液0.03%「SEC」) Jaapan - inglise - すりの適正使用協議会 RAD-AR Council, Japan

bimatoprost ophthalmic solution 0.03% "sec" (ビマトプロスト点眼液0.03%「sec」)

santen pharmaceutical co.,ltd. - bimatoprost - limpid and colorless, ophthalmic solution, 2.5ml, (bottle) clear and colorless, (cap) white [label of vivid green wave design]

Ganfort Euroopa Liit - inglise - EMA (European Medicines Agency)

ganfort

allergan pharmaceuticals ireland - bimatoprost, timolol - glaucoma, open-angle, ocular hypertension - ophthalmologicals, - reduction of intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.

GANFORT Iisrael - inglise - Ministry of Health

ganfort

abbvie biopharmaceuticals ltd, israel - bimatoprost; timolol as maleate - eye drops, solution - bimatoprost 0.3 mg/ml; timolol as maleate 5 mg/ml - timolol - timolol - reduction of intraocular pressure in patients with open- angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.

Lumigan Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

lumigan

abbvie limited - bimatoprost 0.3 mg/ml;   - eye drops, solution - 0.3 mg/ml - active: bimatoprost 0.3 mg/ml   excipient: benzalkonium chloride citric acid monohydrate dibasic sodium phosphate heptahydrate hydrochloric acid purified water sodium chloride sodium hydroxide - monotherapy for the reduction of elevated intraocular pressure (iop) in patients with chronic glaucoma or ocular hypertension; or as adjunctive therapy in patients not adequately controlled on other agents.

Ganfort® 0.3/5 Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

ganfort® 0.3/5

abbvie limited - bimatoprost 0.3 mg/ml;  ; timolol maleate 6.8 mg/ml equivalent to 5 mg/ml timolol;   - eye drops, solution - active: bimatoprost 0.3 mg/ml   timolol maleate 6.8 mg/ml equivalent to 5 mg/ml timolol   excipient: benzalkonium chloride citric acid monohydrate dibasic sodium phosphate heptahydrate hydrochloric acid purified water sodium chloride sodium hydroxide

Ganfort Eye Drops Singapur - inglise - HSA (Health Sciences Authority)

ganfort eye drops

abbvie pte. ltd. - bimatoprost; timolol maleate 6.8mg/ml eqv. to timolol base - solution, sterile - 0.3mg/ml - bimatoprost 0.3mg/ml; timolol maleate 6.8mg/ml eqv. to timolol base 5mg/ml

Ganfort PF 0.3/5 Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

ganfort pf 0.3/5

abbvie limited - bimatoprost 300 µg/ml;  ; timolol maleate 5 mg/ml;   - eye drops, solution - 300mcg/ml & 5mg/ml - active: bimatoprost 300 µg/ml   timolol maleate 5 mg/ml   excipient: citric acid monohydrate dibasic sodium phosphate heptahydrate hydrochloric acid purified water sodium chloride sodium hydroxide - indicated for the reduction of intraocular pressure (iop) in patients with chronic open-angle glaucoma or ocular hypertension who are insufficiently responsive to monotherapy.

Lumigan PF Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

lumigan pf

abbvie limited - bimatoprost 0.3 mg/ml;   - eye drops, solution - 0.3 mg/ml - active: bimatoprost 0.3 mg/ml   excipient: citric acid monohydrate dibasic sodium phosphate heptahydrate hydrochloric acid purified water sodium chloride sodium hydroxide - indicated as monotherapy for the reduction of elevated intraocular pressure (iop) in patients with chronic glaucoma or ocular hypertension; or as adjunctive therapy in patients not adequately controlled on other agents.